BRPI0507912A - método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo - Google Patents

método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo

Info

Publication number
BRPI0507912A
BRPI0507912A BRPI0507912-8A BRPI0507912A BRPI0507912A BR PI0507912 A BRPI0507912 A BR PI0507912A BR PI0507912 A BRPI0507912 A BR PI0507912A BR PI0507912 A BRPI0507912 A BR PI0507912A
Authority
BR
Brazil
Prior art keywords
increased bone
treating
individual suffering
active compound
therapeutically active
Prior art date
Application number
BRPI0507912-8A
Other languages
English (en)
Inventor
Taru Blom
Lauri Kangas
Risto Lammintausta
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Publication of BRPI0507912A publication Critical patent/BRPI0507912A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

MéTODO PARA O TRATAMENTO OU A PREVENçãO DE OSTEOPOROSE EM UM INDIVìDUO QUE SOFRA DE RENOVAçãO óSSEA AUMENTADA, E USO DE UM COMPOSTO TERAPEUTICAMENTE ATIVO. A invenção refere-se a um método para o tratamento ou a prevenção de osteoporose em um indivíduo que sofra de renovação óssea aumentada, o referido método compreendendo administrar ao referido indivíduo uma quantidade eficaz de um modulador de receptor de estrogênio seletivo (SERM) de estrutura trifenilalqueno ou trifenilalcano, notadamente ospemifeno.
BRPI0507912-8A 2004-02-23 2005-01-19 método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo BRPI0507912A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/783,092 US20050187302A1 (en) 2004-02-23 2004-02-23 Method for treatment or prevention of osteoporosis in individuals with high bone turnover
PCT/FI2005/000034 WO2005079776A1 (en) 2004-02-23 2005-01-19 Method for treatment or prevention of osteoporosis in individuals with high bone turnover

Publications (1)

Publication Number Publication Date
BRPI0507912A true BRPI0507912A (pt) 2007-07-10

Family

ID=34861145

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507912-8A BRPI0507912A (pt) 2004-02-23 2005-01-19 método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo

Country Status (11)

Country Link
US (1) US20050187302A1 (pt)
EP (1) EP1718287A1 (pt)
JP (1) JP2007523209A (pt)
CN (1) CN1972680A (pt)
AU (1) AU2005215173A1 (pt)
BR (1) BRPI0507912A (pt)
CA (1) CA2557116A1 (pt)
MX (1) MXPA06009549A (pt)
NO (1) NO20064007L (pt)
RU (1) RU2006133903A (pt)
WO (1) WO2005079776A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
EP1986655A4 (en) * 2006-02-06 2009-12-23 Tethys Bioscience Inc MARKERS ASSOCIATED WITH OSTEOPOROSE AND METHOD OF USE THEREOF
SI2121553T1 (sl) * 2007-02-14 2012-11-30 Hormos Medical Ltd Postopek za pripravo terapevtsko uporabnih trifenilbutenskih derivatov
WO2008099060A2 (en) * 2007-02-14 2008-08-21 Hormos Medical Ltd Methods for the preparation of fispemifene from ospemifene
JP5010034B2 (ja) * 2007-12-28 2012-08-29 エフ．ホフマン−ラ ロシュ アーゲー 生理学的状態の評価
CN102690347B (zh) * 2012-05-18 2014-06-25 北京北方生物技术研究所 分离i型前胶原氨基末端肽的方法
US9321712B2 (en) 2012-10-19 2016-04-26 Fermion Oy Process for the preparation of ospemifene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9418067D0 (en) * 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

Also Published As

Publication number Publication date
RU2006133903A (ru) 2008-03-27
MXPA06009549A (es) 2007-04-10
US20050187302A1 (en) 2005-08-25
WO2005079776A1 (en) 2005-09-01
EP1718287A1 (en) 2006-11-08
NO20064007L (no) 2006-09-21
AU2005215173A1 (en) 2005-09-01
CN1972680A (zh) 2007-05-30
CA2557116A1 (en) 2005-09-01
AU2005215173A8 (en) 2009-09-24
JP2007523209A (ja) 2007-08-16

Similar Documents

Publication Publication Date Title
BRPI0507912A (pt) método para o tratamento ou a prevenção de osteoporose em um indivìduo que sofra de renovação óssea aumentada, e, uso de um composto terapeuticamente ativo
TW200602324A (en) Tetrahydro-indazole cannabinoid modulators cross reference to related applications
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
BRPI0510043A (pt) método de tratamento de dor neuropática usando antagonista de receptor crth2
WO2006015259A3 (en) Compounds and compositions as modulators of steroid hormone nuclear receptors
NO20061925L (no) Farmasoytiske preparater for forebyggelse av overdose eller misbruk
TW200630096A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2006066011A3 (en) Compounds and compositions as modulators of steroidal receptors and calcium channel activities
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
WO2005117870A3 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
NO20064924L (no) Eksperimenteringssikker doseringsform som innbefatter an adsorbent og et skadelig middel
MX2009006339A (es) Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide.
WO2008115469A3 (en) Role of hedgehog signaling in atherosclerosis and cardiovascular disease
WO2007098099A3 (en) Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
EA200702212A1 (ru) Способ лечения или профилактики разрушения кости или остеопороза
WO2005077122A3 (en) Compounds and compositions as lxr modulators
IL174427A0 (en) Transdermal no-generating agents for treating tendinopathy
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
BRPI0718469A2 (pt) Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto.
NO20100268L (no) Anvendelse av gjaercellevegger til behandling og/eller forebygging av hyperinsulinemi
WO2005077124A3 (en) Compounds and compositions as lxr modulators
NO20073104L (no) Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser
DK1893213T3 (da) Kombination af pyrimidylaminobenzamidforbindelser og imatinib til behandling eller forebyggelse af proliferative sygdomme

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: RFERENTE A 3A E 6A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011.